Loading [MathJax]/jax/output/HTML-CSS/config.js
Login
Section Medicine

Gene Expression Analysis of miRNA-21 and miRNA-98 in Hepatic Fibrosis: Molecular Mechanisms and Clinical Relevance

Vol 10 No 1 (2025): June:

Nawras Najah Mubark (1)

(1) Wasit University, College of Science, Department of Forensic Evidence, Iraq
Fulltext View | Download

Abstract:

General Background: Liver fibrosis, a precursor to cirrhosis, arises from chronic liver injury due to factors such as hepatitis infection, alcohol intake, obesity, and smoking. Specific Background: MicroRNAs (miRNAs), especially miR-21 and miR-98, are increasingly recognized for their regulatory roles in hepatic fibrogenesis. Knowledge Gap: Despite evidence of miRNA involvement in liver fibrosis, data on their gene expression patterns in specific populations, such as Iraqi patients, remain limited. Aims: This study aimed to evaluate the differential expression of miRNA-21 and miRNA-98 in liver fibrosis patients compared to healthy controls, and their correlation with clinical variables, particularly hepatitis B and C infections. Results: In a case-control design with 88 patients and 88 controls, RT-PCR analysis showed upregulation of miRNA-21 (1.15 vs. 0.32) and downregulation of miRNA-98 (1.67 vs. 6.33) in patients (P < 0.05). miRNA expression was higher in HBV patients and in females. Novelty: This is the first study in Iraq to reveal the opposing expression profiles of miRNA-21 and miRNA-98 in liver fibrosis, suggesting sex-specific and viral infection-related modulation. Implications: These findings highlight the potential of miRNA-21 and miRNA-98 as biomarkers for fibrosis severity and targets for therapeutic intervention, particularly in HBV-associated liver disease.
Highlight :




  • miRNA-21 is upregulated in liver fibrosis patients, especially with HBV, suggesting a potential role in fibrogenesis.




  • miRNA-98 is downregulated in liver fibrosis, indicating a protective or regulatory function in fibrosis progression.




  • Gender and virus type influence miRNA expression—females and HBV patients show higher gene expression levels.




Keywords: miRNA 21, miRNA 98, RT- PCR, Gene expression, Liver fibrosis

References

H. Wang, Z. Wang, Y. Wang, et al., "miRNA-130b-5p Promotes Hepatic Stellate Cell Activation and the Development of Liver Fibrosis by Suppressing SIRT4 Expression," J. Cell Mol. Med., vol. 25, no. 15, pp. 7381–7394, 2021.

H. Peng, L. Y. Wan, J. J. Liang, Y. Q. Zhang, W. B. Ai, and J. F. Wu, "The Roles of lncRNA in Hepatic Fibrosis," Cell Biosci., vol. 8, p. 63, 2018.

J. Qiu, S. Wu, P. Wang, et al., "miR-488-5p Mitigates Hepatic Stellate Cell Activation and Hepatic Fibrosis via Suppressing TET3 Expression," Hepatol. Int., vol. 17, no. 2, pp. 463–475, 2023.

C. He, B. Shu, Y. Zhou, R. Zhang, and X. Yang, "The miR-139-5p/Peripheral Myelin Protein 22 Axis Modulates TGF-β-Induced Hepatic Stellate Cell Activation and CCl4-Induced Hepatic Fibrosis in Mice," Life Sci., vol. 276, p. 119294, 2021.

J. Liao, Z. Zhang, Q. Yuan, L. Luo, and X. Hu, "The Mouse Anxa6/miR-9-5p/Anxa2 Axis Modulates TGF-β1-Induced Mouse Hepatic Stellate Cell Activation and CCl4-Caused Liver Fibrosis," Toxicol. Lett., vol. 362, pp. 38–49, 2022.

F. Riaz, Q. Chen, K. Lu, et al., "Inhibition of miR-188-5p Alleviates Hepatic Fibrosis by Significantly Reducing the Activation and Proliferation of HSCs Through PTEN/PI3K/AKT Pathway," J. Cell Mol. Med., vol. 25, no. 8, pp. 4073–4087, 2021.

Q. Wang, S. Wei, H. Zhou, et al., "MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression," Front. Cell Dev. Biol., vol. 8, p. 513, 2020.

G. Liu, A. Friggeri, Y. Yang, et al., "miR-21 Mediates Fibrogenic Activation of Pulmonary Fibroblasts and Lung Fibrosis," J. Exp. Med., vol. 207, no. 8, pp. 1589–1597, 2010.

B. N. Chau, C. Xin, J. Hartner, et al., "MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways," Sci. Transl. Med., vol. 4, no. 121, p. 121ra18, 2012.

J. M. Caviglia, J. Yan, M. K. Jang, et al., "MicroRNA-21 and Dicer Are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis," Hepatology, vol. 67, no. 6, pp. 2414–2429, 2018.

J. Beermann, M. T. Piccoli, J. Viereck, and T. Thum, "Non-Coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches," Physiol. Rev., vol. 96, no. 4, pp. 1297–1325, 2016.

K. J. Livak and T. D. Schmittgen, "Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method," Methods, vol. 25, no. 4, pp. 402–408, 2001.

M. A. Kazaal, R. A. Jaythoom, D. Y. Mohammed, et al., "Assessment of the Prevalence of Hypertension Patients Among Patients With Type 2 Diabetes in Al-Diwaniyah Province," in Proc. 2nd Int. Conf. Eng. Sci. Achieve Sustain. Dev. GoalsA, vol. 3092, pp. 020009-1–020009-11, 2023.

C. L. Hart, D. S. Morrison, G. D. Batty, et al., "Effect of Body Mass Index and Alcohol Consumption on Liver Disease: Analysis of Data From Two Prospective Cohort Studies," BMJ, vol. 340, p. c1240, 2010.

B. Liu, A. Balkwill, G. Reeves, et al., "Body Mass Index and Risk of Liver Cirrhosis in Middle Aged UK Women: Prospective Study," BMJ, vol. 340, p. c912, 2010.

M. Ventura-Cots, A. E. Watts, and R. Bataller, "Binge Drinking as a Risk Factor for Advanced Alcoholic Liver Disease," Liver Int., vol. 37, pp. 1281–1283, 2017.

R. Kumarswamy, I. Volkmann, and T. Thum, "Regulation and Function of miRNA-21 in Health and Disease," RNA Biol., vol. 8, no. 5, pp. 706–713, 2011.

H. Zhu, H. Luo, Y. Li, et al., "MicroRNA-21 in Scleroderma Fibrosis and Its Function in TGF-β-Regulated Fibrosis-Related Genes Expression," J. Clin. Immunol., vol. 33, no. 6, pp. 1100–1109, 2013.

N. Ludwig, P. Leidinger, K. Becker, et al., "Distribution of miRNA Expression Across Human Tissues," Nucleic Acids Res., vol. 44, no. 8, pp. 3865–3877, 2016.

P. Sarnow, C. L. Jopling, K. L. Norman, et al., "MicroRNAs: Expression, Avoidance and Subversion by Vertebrate Viruses," Nat. Rev. Microbiol., vol. 4, no. 9, pp. 651–659, 2006.

P. Damania, B. Sen, S. B. Dar, et al., "Hepatitis B Virus Induces Cell Proliferation via HBx-Induced MicroRNA-21 in Hepatocellular Carcinoma by Targeting Programmed Cell Death Protein4 (PDCD4) and Phosphatase and Tensin Homologue (PTEN)," PLoS One, vol. 9, no. 3, p. e91745, 2014.

J. M. Caviglia, J. Yan, M. K. Jang, et al., "MicroRNA-21 and Dicer Are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis," Hepatology, vol. 67, no. 6, pp. 2414–2429, 2018.

Z. Hou and J. Quan, "Hepatitis B Virus X Protein Increases MicroRNA-21 Expression and Accelerates the Development of Hepatoma via the Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/Protein Kinase B Signaling Pathway," Mol. Med. Rep., vol. 15, no. 5, pp. 3285–3291, 2017.

S. Bandiera, S. Pernot, H. El Saghire, et al., "Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated With Liver Disease Pathogenesis," J. Virol., vol. 90, no. 14, pp. 6387–6400, 2016.

R. T. Marquez, S. Bandyopadhyay, E. B. Wendlandt, et al., "Correlation Between MicroRNA Expression Levels and Clinical Parameters Associated With Chronic Hepatitis C Viral Infection in Humans," Lab Invest., vol. 90, no. 12, pp. 1727–1736, 2010.

Y. Chen, J. Chen, H. Wang, et al., "HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1," PLoS Pathog., vol. 9, no. 4, p. e1003248, 2013.

Q. Wang, S. Wei, H. Zhou, et al., "MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression," Front. Cell Dev. Biol., vol. 8, p. 513, 2020.

Y. Ma, X. Yuan, M. Han, et al., "miR-98-5p as a Novel Biomarker Suppresses Liver Fibrosis by Targeting TGFβ Receptor 1," Hepatol. Int., vol. 16, no. 3, pp. 614–626, 2022.

T. Jiang, M. Li, Q. Li, Z. Guo, X. Sun, and X. Zhang, et al., "MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1," Oncol. Res., vol. 25, no. 7, pp. 1117–1127, 2017.

Y. H. Fan, M. H. Ye, L. Wu, et al., "Overexpression of miR-98 Inhibits Cell Invasion in Glioma Cell Lines via Downregulation of IKKε," Eur. Rev. Med. Pharmacol. Sci., vol. 19, no. 19, pp. 3593–3604, 2015.

V. Siragam, Z. J. Rutnam, W. Yang, et al., "MicroRNA miR-98 Inhibits Tumor Angiogenesis and Invasion by Targeting Activin Receptor-Like Kinase-4 and Matrix Metalloproteinase-11," Oncotarget, vol. 3, no. 11, pp. 1370–1385, 2012.

D. M. Patrick, R. L. Montgomery, X. Qi, et al., "Stress-Dependent Cardiac Remodeling Occurs in the Absence of MicroRNA-21 in Mice," J. Clin. Invest., vol. 120, no. 11, pp. 3912–3916, 2010.

G. Yang, X. Zhang, and J. Shi, "MiR-98 Inhibits Cell Proliferation and Invasion of Non-Small Cell Carcinoma Lung Cancer by Targeting PAK1," Int. J. Clin. Exp. Med., vol. 8, no. 11, pp. 20135–20145, 2015.

G. Szabo and S. Bala, "MicroRNAs in Liver Disease," Nat. Rev. Gastroenterol. Hepatol., vol. 10, no. 9, pp. 542–552, 2013.